Downregulation of MicroRNA MiR-520h by E1A Contributes to Anticancer Activity

Overview

Journal Cancer Res

Specialty Oncology

Date 2010 May 27

PMID 20501832

Citations 30

Authors

Jen-Liang Su

Poshen B Chen

Ya-Huey Chen

Shang-Chih Chen

Yi-Wen Chang

Yi-Hua Jan

Xiaoyun Cheng

Michael Hsiao

Mien-Chie Hung

Affiliations

Soon will be listed here.

Abstract

The leading cause of death in cancer patients is cancer metastasis, for which there is no effective treatment. MicroRNAs (miRNA) have been shown to play a significant role in cancer metastasis through regulation of gene expression. The adenovirus type 5 E1A (E1A) is associated with multiple tumor-suppressing activities including the inhibition of metastasis, and E1A gene therapies have been tested in several clinical trials. However, the mechanisms involved in E1A-mediated tumor-suppressing activities are not yet completely defined. Here, we showed that E1A downregulated the expression of the miRNA miR-520h, which was critical for E1A-mediated cancer cell mobility and in vitro invasion activity. In addition, we identified a signal cascade, namely, E1A-->miRNA-520h-->PP2A/C-->IkappaB kinase-->NF-kappaB-->Twist, in which E1A inhibited the expression of Twist through downregulation of miR-520h and the signal cascade. Our results indicated a functional link between miR-520h and tumorigenicity/invasive ability and provided a new insight into the role of E1A-mediated miRNA regulation in tumor suppression. Therefore, the results identified a new cascade of E1A-mediated tumor suppression activity via downregulation of miRNA-520h expression.

Citing Articles

Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway.

Ren L, Jiang M, Xue D, Wang H, Lu Z, Ding L Int J Biol Sci. 2022; 18(13):5207-5220.

PMID: 35982887 PMC: 9379395. DOI: 10.7150/ijbs.69373.

Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.

Huang Z, Su G, Bi X, Zhang L, Xu Z, Wang G Bioengineered. 2021; 12(1):6952-6966.

PMID: 34516353 PMC: 8806836. DOI: 10.1080/21655979.2021.1975016.

Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis.

Li P, Wang H, Tang Y, Sun S, Ma Y, Xu Y Exp Ther Med. 2021; 22(4):1142.

PMID: 34504588 PMC: 8393733. DOI: 10.3892/etm.2021.10576.

miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer.

Geng W, Song H, Zhao Q, Dong K, Pu Q, Gao H Biomed Res Int. 2020; 2020:9512793.

PMID: 32775453 PMC: 7391095. DOI: 10.1155/2020/9512793.

miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.

Zhang H, Lang T, Zou D, Zhou L, Lou M, Liu J Onco Targets Ther. 2020; 12:11691-11700.

PMID: 32021247 PMC: 6942529. DOI: 10.2147/OTT.S236607.

References

Hung M, Hortobagyi G, Ueno N . Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer. Adv Exp Med Biol. 2000; 465:171-80. DOI: 10.1007/0-306-46817-4_16. View

Yoo G, Hung M, Lopez-Berestein G, Lafollette S, Ensley J, Carey M . Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. Clin Cancer Res. 2001; 7(5):1237-45. View

Mazzarelli J, Atkins G, Geisberg J, Ricciardi R . The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110. Oncogene. 1995; 11(9):1859-64. View

Yu D, Hamada J, Zhang H, Nicolson G, Hung M . Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene. 1992; 7(11):2263-70. View

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

Madhusudan S, Tamir A, Bates N, Flanagan E, Gore M, Barton D . A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. Clin Cancer Res. 2004; 10(9):2986-96. DOI: 10.1158/1078-0432.ccr-03-0291. View

Chen C, Ridzon D, Broomer A, Zhou Z, Lee D, Nguyen J . Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33(20):e179. PMC: 1292995. DOI: 10.1093/nar/gni178. View

Geisberg J, Chen J, Ricciardi R . Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex. Mol Cell Biol. 1995; 15(11):6283-90. PMC: 230880. DOI: 10.1128/MCB.15.11.6283. View

Thiery J . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6):442-54. DOI: 10.1038/nrc822. View

10.

Frisch S, Mymryk J . Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol. 2002; 3(6):441-52. DOI: 10.1038/nrm827. View

11.

Yang M, Wu K . TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle. 2008; 7(14):2090-6. DOI: 10.4161/cc.7.14.6324. View

12.

Byrd P, Grand R, Gallimore P . Differential transformation of primary human embryo retinal cells by adenovirus E1 regions and combinations of E1A + ras. Oncogene. 1988; 2(5):477-84. View

13.

Ruley H . Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 1983; 304(5927):602-6. DOI: 10.1038/304602a0. View

14.

Harfe B . MicroRNAs in vertebrate development. Curr Opin Genet Dev. 2005; 15(4):410-5. DOI: 10.1016/j.gde.2005.06.012. View

15.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

16.

Ravdin P, Cronin K, Howlader N, Berg C, Chlebowski R, Feuer E . The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007; 356(16):1670-4. DOI: 10.1056/NEJMsr070105. View

17.

Liao Y, Hung M . A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells. Cancer Res. 2004; 64(17):5938-42. DOI: 10.1158/0008-5472.CAN-04-1533. View

18.

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

19.

Yu D, Wolf J, Scanlon M, Price J, Hung M . Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res. 1993; 53(4):891-8. View

20.

Yu D, Scorsone K, Hung M . Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene. Mol Cell Biol. 1991; 11(3):1745-50. PMC: 369488. DOI: 10.1128/mcb.11.3.1745-1750.1991. View